The 5 most popular stories on Africa Private Equity News the past week

Chinese capital rides the EV narrative

Spiro, an African electric vehicle platform, closed its latest round at $270 million. The final tranche: $55 million from NewTrails Capital, a Chinese growth-stage fund. The stated use of proceeds is manufacturing and supply chain localization — specifically locking in Chinese supplier relationships on the ground.

Separately, Impact Fund Denmark closed its SDG Fund II at DKK 5 billion (~$750 million). Five Danish pension funds plus Jyske Bank provided the LP base. The fund targets 13 developing and emerging markets. Already deployed: $150 million+ into five companies, including Africa-facing positions in Sturdee Energy, Imperium Holding — and Spiro, again.

Spiro appearing in both the top-read story and the Danish fund's disclosed portfolio signals a concentration of interest. Two capital sources, one Chinese growth equity, one Nordic development-finance hybrid, both backing the same platform. The bet is clear: localized EV manufacturing with continental distribution. Whether the unit economics support that at scale remains unverified from these disclosures.

Financial services consolidation: Morocco and pharma M&A

IMG Capital, through IMG Fund I, took a minority position in Morocco's Avis Locafinance Group. The target: a company that evolved from a 1961 car rental operator into an integrated mobility platform spanning short-term rental (Avis brand), long-term corporate leasing (Locafinance), and fleet maintenance. Morocco's regulatory environment and proximity to European capital flows make this a predictable jurisdiction for PE entry.

On the pharma side, two deals. Adenia Partners closed its first majority investment in Egypt — a stake in Parkville Pharmaceuticals, operating across pharma, cosmeceuticals, and nutraceuticals. Adenia acquired the position previously held by Admaius Capital Partners. That's a secondary transfer, not fresh primary capital into the business.

Mediterrania Capital Partners announced that its portfolio company Laprophan Group acquired a controlling stake in Rivopharm, a Swiss specialty pharma and complex-formulation house. This is a cross-border bolt-on — North African platform buying European manufacturing capability. The thesis: bring formulation IP downstream into African distribution.

Sustainable finance at scale

Standard Bank acted as sole mandated lead arranger, underwriter, and sustainability coordinator on a $175 million syndicated sustainable financing for Wilderness Holdings. Structure: $125 million five-year term facility plus a $50 million revolving credit facility, senior secured. This is balance-sheet-level financing, not VC. Wilderness operates in nature-based tourism — the deal structure suggests the sustainability label is driving pricing advantages.

What the reading list actually reveals

Strip the narratives. The capital allocation pattern across these five stories breaks down as follows:

• EV and mobility infrastructure: $270M (Spiro) + minority stake (Avis Locafinance)

• Pharma and healthcare: undisclosed majority (Parkville) + undisclosed bolt-on (Rivopharm)

• Sustainable/ESG-linked finance: $175M (Wilderness) + $750M fund with Africa allocation

Three sectors. Three theses. No fintech, no crypto, no SaaS. The most-read stories on Africa's PE beat are hardware-heavy, asset-intensive, and ESG-labeled. That's where the eyeballs — and the term sheets — are concentrating.

What to watch: Spiro's post-money valuation remains undisclosed in these sources. The $270M round implies a significant number. Any LP running Africa allocation models needs that figure before benchmarking the EV thesis against comparable EM plays. The data isn't in the public disclosures yet.